Atlas Trials

AI Based Multi-modal Parameter of Peripheral Blood Cells (MMPBC) Predicts Survival Risk in Critically Ill Children

Clinical trial NCT06034639 · UNKNOWN

Trial details

NCT number
NCT06034639
Sponsor
Zhujiang Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Children
Start date
2023-03-01
Primary completion
2023-09-30
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.